WO2011064558A3 - Pharmaceutical composition - Google Patents

Pharmaceutical composition Download PDF

Info

Publication number
WO2011064558A3
WO2011064558A3 PCT/GB2010/002199 GB2010002199W WO2011064558A3 WO 2011064558 A3 WO2011064558 A3 WO 2011064558A3 GB 2010002199 W GB2010002199 W GB 2010002199W WO 2011064558 A3 WO2011064558 A3 WO 2011064558A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
relates
liposomes
medicament
pharmaceutically acceptable
Prior art date
Application number
PCT/GB2010/002199
Other languages
French (fr)
Other versions
WO2011064558A2 (en
Inventor
Amar Lulla
Geena Malhotra
Original Assignee
Cipla Limited
Curtis, Philip, Anthony
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Limited, Curtis, Philip, Anthony filed Critical Cipla Limited
Publication of WO2011064558A2 publication Critical patent/WO2011064558A2/en
Publication of WO2011064558A3 publication Critical patent/WO2011064558A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to a pharmaceutical composition comprising liposomes and at least one pharmaceutically acceptable excipient, wherein the liposomes comprise a lipid core containing voriconazole. The invention also relates to a method of making pharmaceutical compositions and to their use as a medicament.
PCT/GB2010/002199 2009-11-30 2010-11-30 Pharmaceutical composition WO2011064558A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2766/MUM/2009 2009-11-30
IN2766MU2009 2009-11-30

Publications (2)

Publication Number Publication Date
WO2011064558A2 WO2011064558A2 (en) 2011-06-03
WO2011064558A3 true WO2011064558A3 (en) 2012-02-02

Family

ID=43498486

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2010/002199 WO2011064558A2 (en) 2009-11-30 2010-11-30 Pharmaceutical composition

Country Status (1)

Country Link
WO (1) WO2011064558A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
MX2014013714A (en) * 2012-05-11 2015-08-10 Cipla Ltd Pharmaceutical composition.
EP3021844B1 (en) * 2013-07-17 2019-11-13 Council of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
WO2015051183A1 (en) 2013-10-03 2015-04-09 Dow Pharmaceutical Sciences, Inc. Stabilized efinaconazole compositions
CN105848719A (en) 2013-11-22 2016-08-10 道尔医药科学公司 Anti-infective methods, compositions, and devices
US9981041B2 (en) 2016-08-23 2018-05-29 Ira Jason Salzman Ophthalmic lubricating spray

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063213A1 (en) * 2003-12-19 2005-07-14 Biodelivery Sciences International, Inc. Rigid liposomal cochleate and methods of use and manufacture
CN1669554A (en) * 2004-03-17 2005-09-21 昆明希捷医药研发有限公司 Liposome vitality conazole preparation
KR20090062707A (en) * 2007-12-13 2009-06-17 재단법인서울대학교산학협력재단 Liposomal external preparation comprising triazole derivative antifungal agent and preparation method thereof
GB2458080A (en) * 2006-12-18 2009-09-09 Suzhou Shilin Pharma Tech Co Ltd Sterols modified by polyethylene glycol, the preparation and the use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819308D0 (en) 1988-08-13 1988-09-14 Pfizer Ltd Triazole antifungal agents
US5549910A (en) 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
KR0166088B1 (en) 1990-01-23 1999-01-15 . Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9002375D0 (en) 1990-02-02 1990-04-04 Pfizer Ltd Triazole antifungal agents
GB9602080D0 (en) 1996-02-02 1996-04-03 Pfizer Ltd Pharmaceutical compounds
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
US20030072807A1 (en) 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US20050112204A1 (en) 2003-11-25 2005-05-26 Pfizer Inc. Pharmaceutical formulations

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005063213A1 (en) * 2003-12-19 2005-07-14 Biodelivery Sciences International, Inc. Rigid liposomal cochleate and methods of use and manufacture
CN1669554A (en) * 2004-03-17 2005-09-21 昆明希捷医药研发有限公司 Liposome vitality conazole preparation
GB2458080A (en) * 2006-12-18 2009-09-09 Suzhou Shilin Pharma Tech Co Ltd Sterols modified by polyethylene glycol, the preparation and the use thereof
KR20090062707A (en) * 2007-12-13 2009-06-17 재단법인서울대학교산학협력재단 Liposomal external preparation comprising triazole derivative antifungal agent and preparation method thereof

Also Published As

Publication number Publication date
WO2011064558A2 (en) 2011-06-03

Similar Documents

Publication Publication Date Title
WO2010092090A3 (en) Novel salts of sitagliptin
WO2010146179A3 (en) Solid pharmaceutical composition comprising rivaroxaban
WO2011064558A3 (en) Pharmaceutical composition
WO2012021715A3 (en) Stable formulations of linaclotide
IL215065A (en) Proline derivatives, process for their preparation, pharmaceutical compositions comprising said derivatives and use thereof for the preparation of medicaments
WO2008132229A3 (en) Highly concentrated insulin solutions and compositions
HK1164292A1 (en) Novel tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same
WO2012174158A3 (en) Administration of benzodiazepine
WO2011017502A3 (en) Linaclotide-containing formulations for oral administration
WO2011110939A3 (en) Pharmaceutical compositions of substituted benzhydrylpiperazines
WO2010049449A3 (en) Novel salts of sunitinib
WO2011157721A3 (en) Ivabradine-containing pharmaceutical composition
WO2012053009A3 (en) Pharmaceutical compositions comprising nano size droplets of skin whitening agents
WO2011009938A3 (en) Stambomycin and derivatives, their production and their use as drugs
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
WO2010082220A3 (en) Sustained release pharmaceutical composition of quetiapine and process for preparation thereof
WO2012087255A3 (en) Pharmaceutical formulations comprising imatinib
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
MX2012001691A (en) Orally disintegrating compositions of linaclotide.
IL213671A (en) Pharmaceutical compositions comprising aleglitazar, process for their manufacture and use thereof in the preparation of medicaments
WO2011047837A3 (en) Melt-granulated cinacalcet
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2011067236A3 (en) Raltegravir polymorphs
WO2013074871A3 (en) Humanin analogs

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10785495

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10785495

Country of ref document: EP

Kind code of ref document: A2